CRISPR Therapeutics AG logo CRSP - CRISPR Therapeutics AG

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 22
HOLD 14
SELL 2
STRONG
SELL 0
| PRICE TARGET: $64.60 DETAILS
HIGH: $82.00
LOW: $33.00
MEDIAN: $76.00
CONSENSUS: $64.60
UPSIDE: 28.28%

Profitability Ratios

Ratio Value
GP Margin -6537.0%
EBIT Margin -16191.4%
EBITDA Margin -15636.4%
Operating Margin -16191.4%
Pretax Margin -16466.2%
Cont. Ops Margin -16569.8%
Net Margin -16569.8%
Bottom Line Margin -16569.8%

Liquidity Ratios

Ratio Value
Current Ratio 13.32
Quick Ratio 13.32
Solvency Ratio -1.637
Cash Ratio 2.38

Valuation Ratios

Ratio Value
Price/Earnings
-8.11
Hist. avg: 32.4
Peers avg: 22.7
PEG Ratio -0.17
Forward PEG -0.17
Price/Book 2.45
Price/Sales 1343.50
Price/FCF -13.63
Price/Op Cash Flow -13.67

Debt Ratios

Ratio Value
Debt/Assets 0.1743
Debt/Equity 0.2055
Debt/Capital 0.1705
Long-Term Debt/Capital 0.0892
Financial Leverage 1.18

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.00
Operating Cash Flow Ratio -2.314
Operating Cash Flow/Sales -9829.5%
Free Cash Flow/Operating Cash Flow 100.3%

Coverage Ratios

Ratio Value
Debt Service Coverage -29.74
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage -18.57
Operating Cash Flow Coverage -0.87
Capital Expenditure Coverage -377.48
Dividend + Capital Expenditure Coverage -377.48

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 0.04
EPS -6.468
Debt/Share 4.3916
Cash/Share 22.06
Book Value/Share 21.37
Tangible BV/Share 21.37
Equity/Share 21.37
Operating Cash Flow/Share -3.837
Capital Expenditure/Share 0.010
FCF/Share -3.847

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.006
Earnings Before Tax/EBIT 1.017
Price/Fair Value 2.45
Debt/Market Cap 0.0438
Effective Tax Rate -0.6%
Enterprise Value Multiple -8.66